Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare Conferences
September 01 2016 - 8:30AM
Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
renal disease, today announced it will webcast management
presentations at the following investor conferences:
- Baird’s 2016 Global Healthcare Conference in New York on
Thursday, September 8, 2016 at 9:40 a.m. Eastern Time.
- A fireside chat at the Morgan Stanley Global Healthcare
Conference in New York on Tuesday, September 13, 2016 at 12:20 p.m.
Eastern Time.
Live audio webcasts of the presentations will be
accessible from Keryx’s website at http://investors.keryx.com
within the Investor Relations section under the “webcasts and
presentations” page. Archived versions of the webcasts will be
available for at least 15 days following the conclusion of the live
presentation.
About Keryx Biopharmaceuticals,
Inc. Keryx Biopharmaceuticals, with headquarters in
Boston, is focused on bringing innovative medicines to people with
renal disease. In December 2014, the company launched its first
FDA-approved medicine, Auryxia® (ferric citrate) in the United
States. In January 2014, ferric citrate was approved for use
in Japan, where it is being marketed as Riona® by Keryx's Japanese
partner, Japan Tobacco Inc. and Torii Pharmaceutical Co. Ltd. In
September 2015, the European Commission granted European market
authorization for Fexeric® (ferric citrate coordination complex).
For more information about Keryx, please visit www.keryx.com.
KERYX BIOPHARMACEUTICALS CONTACT:
Lora Pike
Senior Director, Investor Relations
T: 617-466-3511
lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Apr 2023 to Apr 2024